CLARMA CAPITAL SLP LIMITED

Clarma Capital is a European‑focused investment firm dedicated to accelerating life‑sciences startups at the cutting edge of medical‑device, medicinal‑product and diagnostic innovation. By providing early‑stage capital, the team works hand‑in‑hand with founders to nurture differentiated technologies, build robust commercial teams and chart clear exit pathways. Their investment philosophy centres on regulated products with sizeable addressable markets, ensuring that each portfolio company has the strategic support needed to scale rapidly.

Operating from hubs in London, Switzerland, Dublin and across Central Europe, Clarma Capital leverages an extensive network to unlock follow‑on funding, forge strategic partnerships with hospitals, research institutes and industry players, and drive operational efficiencies. Whether it is refining cost structures, enhancing scalability or connecting entrepreneurs with venture‑capital partners, the firm’s collaborative approach is designed to turn scientific breakthroughs into market‑ready solutions that transform healthcare.